
CYBERDYNE Inc.
7779.TJPXHealthcareMedical - Devices
Latest quote
¥235
¥0.00 · 0.00%
7779.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteHeadquartered in Tsukuba, Japan, and founded in 2004, CYBERDYNE Inc. is dedicated to the ongoing research, development, production, sales, leasing, and maintenance of sophisticated equipment and systems, primarily for the medical and defense sectors within Japan. Their innovative product line features the Hybrid Assistive Limb (HAL), available in medical variants for lower limbs and single joints, as well as non-medical versions designed for lower limbs, single joints, and lumbar support. The company also supplies HAL peripherals, robotic cleaners, and autonomous transport robots for factories, offices, and various other indoor environments. A notable technological offering is Acoustic X, a high-speed light pulse LED array that facilitates real-time photoacoustic imaging. Complementing their hardware, CYBERDYNE provides specialized treatments and programs such as Cybernics Treatment, which utilizes HAL to restore or enhance function for individuals suffering from conditions like spinal cord injuries, strokes, and neuromuscular disorders. They additionally offer HAL FIT and Neuro HALFIT to improve brain-nerve-musculoskeletal and general physical functions, respectively, and MTX Neuro HAL Plus to optimize brain-nerve performance in athletes. Furthermore, the company extends its expertise to critical areas including disaster rescue operations, heavy industrial labor assistance, and contributions to the entertainment industry.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- JP
- CEO
- Yoshiyuki Sankai
- Listed since
- Mar 26, 2014
- Employees
- 203
Market position
Day range
Current ¥235
52-week range
Current ¥235
- Open
- ¥236
- Previous close
- ¥235
- Volume
- 473.5K
- 0.24× average
- Average volume
- 1.96M
- Average daily volume
- Market cap
- 31.36B JPY
- Beta
- 0.84
- Market reference 1
- 50-day average
- ¥236.58
- -0.67% below average
- 200-day average
- ¥256.59
- -8.41% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- P/E (TTM)
- 180.77×
- P/B (TTM)
- 1.24×
- P/S (TTM)
- 8.1×
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 49.47%
- Operating margin
- -26.83%
- Net margin
- 7.13%
Financial health
- Debt / equity
- 0.01×
- Altman Z-score
- 2.3
- Piotroski F-score
- 5 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (JPY) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 3.85B JPY | 4.38B JPY | 4.35B JPY | 3.29B JPY | 2.15B JPY |
| Cost of goods sold | 1.58B JPY | 2.32B JPY | 2.33B JPY | 1.8B JPY | 897M JPY |
| Gross profit | 2.27B JPY | 2.07B JPY | 2.03B JPY | 1.49B JPY | 1.25B JPY |
| Research and development | 1B JPY | 1.07B JPY | 877M JPY | 735M JPY | 713M JPY |
| Selling, general, and administrative | 1.96B JPY | 2.43B JPY | 2.82B JPY | 2B JPY | 1.48B JPY |
| Operating expenses | 3.37B JPY | 3.56B JPY | 3.76B JPY | 2.84B JPY | 2.3B JPY |
| Interest income | 1.19B JPY | 45M JPY | 25M JPY | 26M JPY | 19M JPY |
| Interest expense | 273M JPY | 303M JPY | 482M JPY | 193M JPY | 4M JPY |
| Depreciation and amortization | 613M JPY | 592M JPY | 677M JPY | 627M JPY | 482M JPY |
| Operating income | −1.1B JPY | −1.5B JPY | −1.74B JPY | −1.35B JPY | −1.05B JPY |
| Net income | 153M JPY | −577M JPY | −1.48B JPY | −298M JPY | −498M JPY |
Company facts updated Aug 24, 2026.
Earnings
- Latest EPS result
- 1.73
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Corporate actions
Corporate action history
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Jul 29, 2015 | 2:1 | — | — |
Stock split | Jul 29, 2014 | 5:1 | — | — |
Effective Jul 29, 2015
2:1
Effective Jul 29, 2014
5:1
Continue in GoAI
Research 7779.Tresearch.disclaimer